[Hyperhomocysteinemia. A risk factor for the development of vascular diseases not associated with lipid levels]

H Hyánek1, J Stríbrný, P Sebesta

  • 1Oddĕlení klinické biochemie, nemocnice Na Homolce, Praha.

Casopis Lekaru Ceskych
|February 26, 1998
PubMed

Insights

Elevated total homocysteine, a factor in vascular damage, showed no clear link to lipid levels in patients undergoing arterial bypass or from lipid clinics. Further research is needed to understand this complex relationship.

Area of Science:

  • Cardiovascular Science
  • Clinical Biochemistry
  • Nutritional Science

Context:

  • Elevated total homocysteine is linked to vascular damage, particularly in patients with atherosclerotic conditions.
  • Understanding the relationship between homocysteine and lipid metabolism is crucial for assessing cardiovascular risk.
  • Patients with atherosclerotic vascular damage often present with elevated homocysteine levels.

Purpose:

  • To investigate the correlation between total plasma homocysteine levels and various lipid indicators.
  • To determine if homocysteine acts as a lipid-dependent or lipid-independent risk factor in cardiovascular disease.
  • To examine the relationship in healthy subjects and patients with specific vascular conditions.

Summary:

  • A study involving 100 healthy subjects and 529 patients examined the association between total homocysteine and lipid markers like total cholesterol, HDL-cholesterol, LDL-cholesterol, triacylglycerols, apolipoproteins, and Lp(a).
  • Correlations found were weak, with coefficients ranging from -0.12 to 0.29 for lipid indicators.
  • Folate levels showed a moderate correlation (r=0.28) with homocysteine, while vitamin B12 and fibrinogen showed negligible associations.
  • No unequivocal relationship was detected between total homocysteine and selected lipid indicators across patient groups.

Impact:

  • The findings suggest that homocysteine's role in vascular damage may not be directly explained by its interaction with common lipid parameters.
  • This study highlights the complexity of cardiovascular risk factors, indicating that homocysteine's impact might be mediated through pathways independent of lipid metabolism.
  • Further research is warranted to elucidate the precise mechanisms by which homocysteine contributes to vascular pathology.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...